For Investors

Are you ready to be part of the next big thing?

Why to invest
on us

IPLEXMED's NexaGuard, a portable, lab-grade diagnostic platform, to be used both by clinicians and at home by patients. The praticability of a rapid diganostic test, with the power of molecular diagnosis.
1 electronic device (NexaGuard)
Disposable multiplex cartridges for different applications
Software with AI for better previsions


Why diagnosis of respiratory infection and

AMR in chronic respiratory disease patients?

There is no adequate first-line molecular diagnostic tool, which increases time to informed diagnosis, impacting patient exacerbations, hospitalization and death.
6% of the global population is at risk of contracting a Chronic Respiratory Diseases
3rd leading cause of death worldwide
1 Bn of chronic respiratory disease patients
3 Mn premature deaths/y due to respiratory infections
12 Bn euro market
Know More

A revolution for patients, healthcare providers,
payers and medical doctors

Impacting patient lives and healthcare providers management, whyle reducing the costs for health care payers, and relive physicians for the work that matters.


The power of molecular diagnosis
in our hands

First in class with the capacity to diagnose multiple bacteria and AMR at ER and at home, in just 20 minutes.
Convenience for ER and at Home
Bacterial infections and AMR
Multiplexing of 30 different analysis
Just 20 minutes
Easy to use

Feel free to get in
Touch!

Name*
Please fill in the Name
Email*
Please fill in the email
Phone*
Please fill in the phone
Message*
Please describe the reason for contact
Request submitted successfully!
We will contact you as soon as possible.